Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The diagnosis and treatment plan for hepatocellular carcinoma (HCC) can be made from radiologic imaging. However, lesion detection may vary depending on the imaging modality. This study aims to evaluate the sensitivities of hepatic multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), and digital subtraction angiography (DSA) in the detection of HCC and the consequent management impact on potential liver transplant patients. Methods: One hundred and sixteen HCC lesions were analyzed in 41 patients who received an orthotopic liver transplant (OLT). All of the patients underwent pretransplantation hepatic DSA, MDCT, and/or MRI. The imaging results were independently reviewed retrospectively in a blinded fashion by two interventional and two abdominal radiologists. The liver explant pathology was used as the gold standard for assessing each imaging modality. Results: The sensitivity for overall HCC detection was higher for cross-sectional imaging using MRI (51.5%, 95% confidence interval [CI]=36.2-58.4%) and MDCT (49.8%, 95% CI=43.7-55.9%) than for DSA (41.7%, 95% CI=36.2-47.3%) (P=0.05). The difference in false-positive rate was not statistically significant between MRI (22%), MDCT (29%), and DSA (29%) (P=0.67). The sensitivity was significantly higher for detecting right lobe lesions than left lobe lesions for all modalities (MRI: 56.1% vs. 43.1%, MDCT: 55.0% vs. 42.0%, and DSA: 46.9% vs. 33.9%; all P<0.01). The sensitivities of the three imaging modalities were also higher for lesions ≥2 cm vs. <2 cm (MRI: 73.4% vs. 32.7%, MDCT: 66.9% vs. 33.8%, and DSA: 62.2% vs. 24.1%; all P<0.01). The interobserver correlation was rated as very good to excellent. Conclusions: The sensitivity for detecting HCC is higher for MRI and MDCT than for DSA, and so cross-sectional imaging modalities should be used to evaluate OLT candidacy. (Clin Mol Hepatol 2016;22:450-457)
Abstract
Background/Aims: The diagnosis and treatment plan for hepatocellular carcinoma (HCC) can be made from radiologic imaging. However, lesion detection may vary depending on the imaging modality. This study aims to evaluate the sensitivities of hepatic multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), and digital subtraction angiography (DSA) in the detection of HCC and the consequent management impact on potential liver transplant patients. Methods: One hundred and sixteen HCC lesions were analyzed in 41 patients who received an orthotopic liver transplant (OLT). All of the patients underwent pretransplantation hepatic DSA, MDCT, and/or MRI. The imaging results were independently reviewed retrospectively in a blinded fashion by two interventional and two abdominal radiologists. The liver explant pathology was used as the gold standard for assessing each imaging modality. Results: The sensitivity for overall HCC detection was higher for cross-sectional imaging using MRI (51.5%, 95% confidence interval [CI]=36.2-58.4%) and MDCT (49.8%, 95% CI=43.7-55.9%) than for DSA (41.7%, 95% CI=36.2-47.3%) (P=0.05). The difference in false-positive rate was not statistically significant between MRI (22%), MDCT (29%), and DSA (29%) (P=0.67). The sensitivity was significantly higher for detecting right lobe lesions than left lobe lesions for all modalities (MRI: 56.1% vs. 43.1%, MDCT: 55.0% vs. 42.0%, and DSA: 46.9% vs. 33.9%; all P<0.01). The sensitivities of the three imaging modalities were also higher for lesions ≥2 cm vs. <2 cm (MRI: 73.4% vs. 32.7%, MDCT: 66.9% vs. 33.8%, and DSA: 62.2% vs. 24.1%; all P<0.01). The interobserver correlation was rated as very good to excellent. Conclusions: The sensitivity for detecting HCC is higher for MRI and MDCT than for DSA, and so cross-sectional imaging modalities should be used to evaluate OLT candidacy. (Clin Mol Hepatol 2016;22:450-457)
참고문헌 (32)
- Patel M, "Hepatocellular carcinoma: diagnostics and screening", J Eval Clin Pract, 18, pp.335~342 (2012)
- Saar B, "Radiological diagnosis of hepatocellular carcinoma", Liver Int, 28, pp.189~199 (2008)
- Siegel R, "Cancer Facts & Figures 2012", American Cancer Society, 1~64 (2012)
- Centers for Disease Control and Prevention (CDC), "Hepatocellular carcinoma - United States, 2001-2006", MMWR Morb Mortal Wkly Rep, 59, pp.517~520 (2010)
- Altekruse SF, "Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005", J Clin Oncol, 27, pp.1485~1491 (2009)
- Altekruse SF, "Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008", Hepatology, 55, pp.476~482 (2012)
- Hauboldt RH, "2008 U. S. organ and tissue transplant cost estimates and discussion", Milliman, Inc., 1~20 (2008)
- Benson AB 3rd, "NCCN clinical practice guidelines in oncology: hepatobiliary cancers", J Natl Compr Canc Netw, 7, pp.350~391 (2009)
- Bruix J, "Management of hepatocellular carcinoma", Hepatology, 42, pp.1208~1236 (2005)
- McCaughan GW, "Hepatocellular carcinoma: current approaches to diagnosis and management", Intern Med J, 32, pp.394~400 (2002)
- Murray KF, "AASLD practice guidelines: Evaluation of the patient for liver transplantation", Hepatology, 41, pp.1407~1432 (2005)
- Mazzaferro V, "Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis", N Engl J Med, 334, pp.693~699 (1996)
- Yao FY, "Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria", Liver Transpl, 8, pp.765~774 (2002)
- Fowler KJ, "Validation of organ procurement and transplant network (OPTN)", united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma, 2013, pp.95, 1506~1511
- Iwazawa J, "Detection of hepatocellular carcinoma: comparison of angiographic Carm CT and MDCT", AJR Am J Roentgenol, 195, pp.882~887 (2010)
- Bruix J, "Clinical Management of Hepatocellular Carcinoma: Conclusions of the Barcelona-2000 EASL Conference", J Hepatol, 35, pp.421~430 (2001)
- Bruix J, "Management of hepatocellular carcinoma: an update", Hepatology, 53, pp.1020~1022 (2011)
- Mazzaferro V, "Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience", Liver Transpl, 17(Suppl 2), pp.S44~S57 (2011)
- Tanwar S, "Liver transplantation for hepatocellular carcinoma", World J Gastroenterol, 15, pp.5511~5516 (2009)
- Addley HC, "Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation", Clin Radiol, 66, pp.349~356 (2011)
- Burrel M, "MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation", Hepatology, 38, pp.1034~1042 (2003)
- Libbrecht L, "Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations", Liver Transpl, 8, pp.749~761 (2002)
- Choi SH, "Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI", AJR Am J Roentgenol, 191, pp.529~536 (2008)
- Steingruber IE, "Pretransplantation evaluation of the cirrhotic liver with explantation correlation: accuracy of CT arterioportography and digital subtraction hepatic angiography in revealing hepatocellular carcinoma", AJR Am J Roentgenol, 181, pp.99~108 (2003)
- Krinsky GA, "Dysplastic nodules and hepatocellular carcinoma: sensitivity of digital subtraction hepatic arteriography with whole liver explant correlation", J Comput Assist Tomogr, 24, pp.628~634 (2000)
- Bartolozzi C, "Small hepatocellular carcinoma. Detection with US, CT, MR imaging, DSA, and Lipiodol-CT", Acta Radiol, 37, pp.69~74 (1996)
- El-Gazzaz G, "Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies", Hepatobiliary Pancreat Dis Int, 12, pp.34~41 (2013)
- Gallix BP, "Streamlined flow in the portal vein: demonstration with MR angiography", J Magn Reson Imaging, 15, pp.603~609 (2002)
- Kashiwagi T, "Heterogeneous intrahepatic distribution of blood flow in humans", Eur J Nucl Med, 6, pp.545~549 (1981)
- Colli A, "Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review", Am J Gastroenterol, 101, pp.513~523 (2006)
- Yu NC, "CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis", Clin Gastroenterol Hepatol, 9, pp.161~167 (2011)
- Brancatelli G, "Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation", AJR Am J Roentgenol, 180, pp.1007~1014 (2003)